Ligand id: 7396

Name: siltuximab

Compound class Antibody
Approved drug? Yes (EMA & FDA (2014))
International Nonproprietary Names
INN number INN
9051 siltuximab
cLLB8 | CNTO 328 | Sylvant®
Siltuximab is a monoclonal antibody targeting interleukin 6 (IL-6) [2].
Peptide sequences for the heavy and light chains of this antibody are annotated in its IMGT/mAb-DB record. The invention of siltuximab is covered by patent US7291721 [1].
Database Links
Specialist databases
IMGT/mAb-DB 297
Other databases
GtoPdb PubChem SID 178103968
Immunopaedia Search siltuximab
PubChem SID 178103968
Search PubMed clinical trials siltuximab
Search PubMed titles siltuximab
Search PubMed titles/abstracts siltuximab
Wikipedia Siltuximab